Ichiro Nakashima

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Venues

Journal of neurology, neurosurgery, and psychiatry

Multiple sclerosis journal - experimental, translational and clinical

Neurology(R) neuroimmunology & neuroinflammation

Multiple sclerosis (Houndmills, Basingstoke, England)

Tohoku Medical and Pharmaceutical University

Tohoku University Graduate School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tohoku Medical and Pharmaceutical University Apr 01 2017

Japan

Professor :: Department of Neurology

Tohoku University School of Medicine Apr 01 1999 - Mar 31 2017

Japan

Associate Professor :: Department of Neurology

Education History

Tohoku University Graduate School of Medicine Apr 01 1994 - Mar 31 1999

Japan

PHD :: Department of Neurology

Publications

Takashi Yamamura, Noriko Isobe, Izumi Kawachi, Chiyoko Nohara, Yusei Miyazaki, Minami Tomita, Takahiko Tsumuraya, Katsuhisa Yamashita, Jin Nakahara, Ichiro Nakashima, Kazuo Fujihara
Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 6-month Interim Analysis of Post-marketing Surveillance. Neurology and therapy (2024)
Kimihiko Kaneko, Hiroshi Kuroda, Yuki Matsumoto, Naohiro Sakamoto, Naoya Yamazaki, Naoki Yamamoto, Shu Umezawa, Chihiro Namatame, Hirohiko Ono, Yoshiki Takai, Toshiyuki Takahashi, Juichi Fujimori, Ichiro Nakashima, Yasuo Harigaya, Hans Lassmann, Kazuo Fujihara, Tatsuro Misu, Masashi Aoki
Different Complement Activation Patterns Following C5 Cleavage in MOGAD and AQP4-IgG+NMOSD. Neurology(R) neuroimmunology & neuroinflammation 11 (5) (2024)
Ichiro Nakashima, Jin Nakahara, Hiroaki Yokote, Yasuhiro Manabe, Kazumi Okamura, Kou Hasegawa, Kazuo Fujihara
Long-term safety and effectiveness of eculizumab in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a 2-year interim analysis of post-marketing surveillance in Japan. Therapeutic advances in neurological disorders 16 (2023)
Masashi Nakamura, Ryo Ogawa, Juichi Fujimori, Akiyuki Uzawa, Yasunori Sato, Kengo Nagashima, Nagato Kuriyama, Satoshi Kuwabara, Ichiro Nakashima
Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide survey. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Satori Ajitomi, Juichi Fujimori, Ichiro Nakashima
Usefulness of two-dimensional measurements for the evaluation of brain volume and disability in multiple sclerosis. Multiple sclerosis journal - experimental, translational and clinical 8 (1) (2022)
Tetsuya Akaishi, Toshiyuki Takahashi, Tatsuro Misu, Kimihiko Kaneko, Yoshiki Takai, Shuhei Nishiyama, Ryo Ogawa, Juichi Fujimori, Tadashi Ishii, Masashi Aoki, Kazuo Fujihara, Ichiro Nakashima
Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder. Neurology 97 (1) (2021)
Juichi Fujimori, Ichiro Nakashima
Reader Response: Teaching Video NeuroImages: Pathologic Yawning: A Sign of Brainstem Involvement in Acute Disseminated Encephalomyelitis? Neurology 96 (23) (2021)
Fumitaka Shimizu, Ryo Ogawa, Yoichi Mizukami, Kenji Watanabe, Kanako Hara, Chihiro Kadono, Toshiyuki Takahashi, Tatsuro Misu, Yukio Takeshita, Yasuteru Sano, Miwako Fujisawa, Toshihiko Maeda, Ichiro Nakashima, Kazuo Fujihara, Takashi Kanda
GRP78 Antibodies Are Associated With Blood-Brain Barrier Breakdown in Anti-Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder. Neurology(R) neuroimmunology & neuroinflammation 9 (1) (2021)
Sean J Pittock, Kazuo Fujihara, Jacqueline Palace, Achim Berthele, Ho Jin Kim, Celia Oreja-Guevara, Ichiro Nakashima, Michael Levy, Shulian Shang, Marcus Yountz, Larisa Miller, Róisín Armstrong, Dean M Wingerchuk, null null
Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension. Multiple sclerosis (Houndmills, Basingstoke, England) (2021)
Iris Kleerekooper, Megan K Herbert, Hinke B Kuiperij, Douglas Kazutoshi Sato, Kazuo Fujihara, Dagoberto Callegaro, Romain Marignier, Albert Saiz, Makbule Senel, Hayrettin Tumani, Brigit A De Jong, S Anand Trip, Ichiro Nakashima, Marcel M Verbeek, Axel Petzold
CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD. Journal of neurology, neurosurgery, and psychiatry 91 (6) (2020)
Yuki Matsumoto, Tatsuro Misu, Shunji Mugikura, Yoshiki Takai, Shuhei Nishiyama, Hiroshi Kuroda, Toshiyuki Takahashi, Juichi Fujimori, Ichiro Nakashima, Kazuo Fujihara, Masashi Aoki
Distinctive lesions of brain MRI between MOG-antibody-associated and AQP4-antibody-associated diseases. Journal of neurology, neurosurgery, and psychiatry (2020)
Lekha Pandit, Sharik Mustafa, Ichiro Nakashima, Toshyuki Takahashi, Kimhiko Kaneko
MOG-IgG-associated disease has a stereotypical clinical course, asymptomatic visual impairment and good treatment response. Multiple sclerosis journal - experimental, translational and clinical 4 (3) (2018)
Kimihiko Kaneko, Douglas Kazutoshi Sato, Ichiro Nakashima, Ryo Ogawa, Tetsuya Akaishi, Yoshiki Takai, Shuhei Nishiyama, Toshiyuki Takahashi, Tatsuro Misu, Hiroshi Kuroda, Satoru Tanaka, Kyoichi Nomura, Yuji Hashimoto, Dagoberto Callegaro, Lawrence Steinman, Kazuo Fujihara, Masashi Aoki
CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications. Journal of neurology, neurosurgery, and psychiatry 89 (9) (2018)
Ichiro Nakashima
Is MOG-IgG another biomarker for neuromyelitis optica? Journal of neurology, neurosurgery, and psychiatry 88 (10) (2017)

Ichiro Nakashima.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ichiro Nakashima